Back to Journals » Therapeutics and Clinical Risk Management » Volume 11

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

Total article views   HTML views PDF downloads Totals
23,372 Dovepress* 18,921+ 2,318 21,239
PubMed Central* 4,451 749 5,200
Totals 23,372 3,067 26,439
*Since 8 October 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar